Actinogen Medical Limited (ACW.AX)
Develops brain medications targeting cortisol to treat Alzheimer's and depression.
0.04-0.05%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+56.0%
The outlook
ACW.AX trades at $0.039, positioned near the lower end of its 52-week range. A single analyst rates it Buy with an average target implying roughly 105% upside from current levels. The stock shows mixed momentum against its moving averages, and the overall StockGlow score sits neutral at 58/100.
What’s behind the score
Analyst consensusBuy — 2.0 avg of 1 analysts
Price trendMixed vs its moving averages
52-week range33% of the way from its 52-week low to high
Price targetAvg target +105% vs current price
Market cap
$145.0M
52-wk high
0.07
52-wk low
0.02
50-day avg
0.04
200-day avg
0.04
Trailing P/E
—